More TSO3 Inc news
TS TSO3 IncTSX: TOS

TSO3 Establishes Medical Industry's First-Ever Claims for Duodenoscope Terminal Sterilization

Dec 17, 2015 at 7:00 AM EST · Issued by TSO3 Inc via CNW

On 6ix: 6ix.com/news/tso3-establishes-medical-industrys-first-ever-claims-for-duodenoscope-terminal-sterilization

Company Contact: TSO, Inc., R.M. (Ric) Rumble, President and CEO, Tel: 418 651-0003, Email: info@tso3.com; Investor Relations: Liolios Group, Inc., Chris Tyson, Tel: 949 574-3860, TOS@liolios.comCopyright CNW Group 2015

View original source (CNW)TSO3 Inc on 6ix

Earlier from TSO3

  • TSO3 and GETINGE Infection Control Sign Exclusive Global Distribution AgreementNov 25, 2015
  • TSO3 Appoints Steve West to Board of DirectorsNov 10, 2015
  • TSO3 Reports Third Quarter 2015 Financial ResultsNov 4, 2015
  • TSO3 Allowed Expanded Claims for Revolutionary STERIZONE® VP4 SterilizerOct 26, 2015
  • TSO3: Q3 2015 Financial Results Conference CallOct 21, 2015

Later from TSO3

  • TSO3 Appoints Glen Kayll as Chief Financial OfficerDec 18, 2015
  • TSO3 to Expand Manufacturing Workforce to Meet Demand for STERIZONE® VP4 SterilizerDec 21, 2015
  • TSO3 Completes Additional Studies, Files Extended U.S. Claims for Breakthrough Medical Device SterilizerDec 22, 2015
  • TSO3 Accelerates Warrant Expiry DateJan 5, 2016
  • TSO3 Appoints Harold R. Tessman as COOJan 27, 2016
All TSO3 news releases↗

Follow TSO3 into a list and get an email when it puts out news.

Follow TSO3
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer